MedTrace Logo

Complex Abdominal Wall Reconstruction Using Biologic Mesh

NCT04780048 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2021-03-03

No results posted yet for this study

Summary

The purpose of this study is to determine how the patient factors, co-morbid conditions, pre-operative workup, anatomy of the defect, reconstruction details, operative techniques, and type of repairs contribute to the final outcome of abdominal wall reconstruction. The outcomes of interest are: in-hospital complications, discharge disposition, hospital and ICU length of stay, long term follow-up (recurrence, reoperation, and explantation rates).

Conditions

  • Hernia

Sponsors & Collaborators

  • New York Medical College

    lead OTHER

Principal Investigators

  • Rifat Latifi, MD · Chairman Department of Surgery

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-07
Primary Completion
2022-07-06
Completion
2022-12-06

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04780048 on ClinicalTrials.gov